30 related articles for article (PubMed ID: 16465215)
1. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia.
Klein E; Ben-Bassat H; Neumann H; Ralph P; Zeuthen J; Polliack A; Vánky F
Int J Cancer; 1976 Oct; 18(4):421-31. PubMed ID: 789258
[TBL] [Abstract][Full Text] [Related]
2. [Detection of bcr/abl fusion gene from K562 cell line and mononuclear cells of CML patients by DNA-PCR].
Xu D; Hu X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):384-9. PubMed ID: 16924701
[TBL] [Abstract][Full Text] [Related]
3. NK3.3-Derived Extracellular Vesicles Penetrate and Selectively Kill Treatment-Resistant Tumor Cells.
McCune A; Kornbluth J
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201518
[TBL] [Abstract][Full Text] [Related]
4. Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.
Morris J; Kunkel MW; White SL; Wishka DG; Lopez OD; Bowles L; Sellers Brady P; Ramsey P; Grams J; Rohrer T; Martin K; Dexheimer TS; Coussens NP; Evans D; Risbood P; Sonkin D; Williams JD; Polley EC; Collins JM; Doroshow JH; Teicher BA
Mol Cancer Ther; 2023 Nov; 22(11):1270-1279. PubMed ID: 37550087
[TBL] [Abstract][Full Text] [Related]
5. Role of Calcium-Activated Potassium Channels in Proliferation, Migration and Invasion of Human Chronic Myeloid Leukemia K562 Cells.
Vasileva VY; Khairullina ZM; Sudarikova AV; Chubinskiy-Nadezhdin VI
Membranes (Basel); 2023 Jun; 13(6):. PubMed ID: 37367787
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected
Vuelta E; Ordoñez JL; Sanz DJ; Ballesteros S; Hernández-Rivas JM; Méndez-Sánchez L; Sánchez-Martín M; García-Tuñón I
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742831
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.
Amarante-Mendes GP; Rana A; Datoguia TS; Hamerschlak N; Brumatti G
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057108
[TBL] [
